Literature DB >> 15310480

The significance and management of persistent primary insomnia: the past, present and future of behavioral insomnia therapies.

J D Edinger1, W K Wohlgemuth.   

Abstract

Persistent primary insomnia (PPI) is a prevalent and potentially serious condition that compromises the functioning, health status, and quality of lives of millions of individuals around the world. This condition is typically perpetuated by a host of psychological and behavioral mechanisms that often require behavioral interventions. Nonetheless, all too commonly, practitioners underestimate the seriousness of this condition or rely too heavily on symptom focused sedative hypnotic therapy for its treatment. Herein we briefly review the epidemiology of PPI and consider the inadequacies of sedative hypnotics for treating this disorder. Subsequently, we provide rationale for the use of behavioral interventions with this condition and we describe the gradual evolution of the currently available behavioral insomnia treatments and consider promising recent developments such as the emergence of cognitive-behavioral and specially tailored, patient-specific approaches. In closing, we consider the potential usefulness of a combined pharmacological/behavioral intervention for PPI and present a number of important research questions to address in future studies of the behavioral insomnia therapies.

Entities:  

Year:  1999        PMID: 15310480     DOI: 10.1016/s1087-0792(99)90018-7

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  11 in total

Review 1.  Insomnia and its treatment in women with breast cancer.

Authors:  Lavinia Fiorentino; Sonia Ancoli-Israel
Journal:  Sleep Med Rev       Date:  2006-09-11       Impact factor: 11.609

2.  Cognitive-behavioral group therapy as an early intervention for insomnia: a randomized controlled trial.

Authors:  Markus Jansson; Steven J Linton
Journal:  J Occup Rehabil       Date:  2005-06

3.  Insomnia in Adults.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2001-01       Impact factor: 3.598

4.  Clinical significance and predictors of treatment response to cognitive-behavior therapy for insomnia secondary to chronic pain.

Authors:  Shawn R Currie; Keith G Wilson; Dorothyann Curran
Journal:  J Behav Med       Date:  2002-04

Review 5.  Basic sleep and circadian science as building blocks for behavioral interventions: a translational approach for mood disorders.

Authors:  Lauren D Asarnow; Adriane M Soehner; Allison G Harvey
Journal:  Behav Neurosci       Date:  2014-04-28       Impact factor: 1.912

6.  Sleep management training for cancer patients with insomnia.

Authors:  Rainer Simeit; Ruth Deck; Beate Conta-Marx
Journal:  Support Care Cancer       Date:  2004-02-04       Impact factor: 3.603

7.  Low Resistance Thought Induction Sleep-regulating Technique (TIP3-2) combined with medication for primary insomnia: a randomized controlled trial.

Authors:  Wei-dong Wang; Gui-xia Li; Lan Hong; Yan-jiao Liu; Yang Zhao; Ying-na Lin; Fang Wang; Tao Li; Xue Yan; Yan-ying Huang
Journal:  Int J Behav Med       Date:  2014-08

Review 8.  Withdrawing benzodiazepines in primary care.

Authors:  Malcolm Lader; Andre Tylee; John Donoghue
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

9.  Impact of musculoskeletal pain on insomnia onset: a prospective cohort study.

Authors:  Nicole K Y Tang; John McBeth; Kelvin P Jordan; Milisa Blagojevic-Bucknall; Peter Croft; Ross Wilkie
Journal:  Rheumatology (Oxford)       Date:  2014-08-14       Impact factor: 7.580

10.  Cost-effectiveness of i-Sleep, a guided online CBT intervention, for patients with insomnia in general practice: protocol of a pragmatic randomized controlled trial.

Authors:  Tanja van der Zweerde; Jaap Lancee; Pauline Slottje; Judith Bosmans; Eus Van Someren; Charles Reynolds; Pim Cuijpers; Annemieke van Straten
Journal:  BMC Psychiatry       Date:  2016-04-02       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.